Abivax

France


Commandez votre montre hebdomadaire Abivax
Quantité totale PI 122
Rang # Quantité totale PI 10 970
Note d'activité PI 2,7/5.0    55
Rang # Activité PI 13 008
Symbole boursier
ISIN FR0012333284
Capitalisation 505.4M  (EUR)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

53 3
32 2
28 2
2
 
Dernier brevet 2025 - Quinoline derivatives for use in...
Premier brevet 2008 - Methods of enhancing adjuvaticit...
Dernière marque 2022 - ABIVAX
Première marque 2015 - ABIVAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention In vitro or ex vivo methods for screening a quinoline derivative. A method of treating an inflam...
Invention Obefazimod for treatment of ulcerative colitis. The present invention relates to Obefazimod or a ...
Invention Phenyl-n-quinoline derivatives for treating a rna virus infection. A compound of formula (I) or a...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. A compound of Formula (...
Invention Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging. The manuf...
2023 Invention Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a...
2022 Invention Method of preparation of 1-(n-(quinolin-2-yl)-(phenylamino)-1-deoxy-beta-d-glucopyranuronic acid ...
Invention Method of preparation of 1-(n-(quinolin-2-yl)- (phenylamino)-1-deoxy-βeta-d-glucopyranuronic acid...
P/S Pharmaceutical preparations for the prevention and treatment of oncologic diseases, autoimmune an...
P/S Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammat...
P/S Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammato...
Invention In vitro or ex vivo methods for screening a quinoline derivative. In vitro or ex vivo methods for...
P/S Pharmaceutical preparations for the prevention of autoimmune, inflammatory, gastrointestinal dise...
P/S Pharmaceutical research and development; drug development and discovery services; medical and sci...
P/S Pharmaceutical preparations for the treatment of autoimmune, inflammatory, gastrointestinal disease
Invention Preparation method of quinoline derivative compounds. A method for preparing a compound of formu...
Invention Preparation method of quinoline derivative compounds. The present invention relates to a method f...
2021 Invention Combinations including abx196 for the treatment of cancer. An antitumor pharmaceutical combinatio...
Invention Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing t...
Invention Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The prese...
Invention Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. Co-crystals an...
Invention Amorphous solid dispersion of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The presen...
Invention Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine. The present inv...
2020 Invention Use of quinoline derivatives for the treatment of inflammatory diseases. The present disclosure r...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (I) is: A co...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. The present invention relates to a co...
Invention Compounds useful for treating cancer. A compound of formula (I): 7 together with the nitrogen at...
Invention Compounds and pharmaceutical compositions containing at least one of the compounds. The present d...
2019 Invention Biomarkers, and uses in treatment of viral infections, inflammations, or cancer. Biomarkers and ...
Invention Quinoline derivatives for use in the treatment or prevention of cancer. A compound of formula (I...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. A compound of Formula (I...
Invention Quinoline derivatives for use in the treatment of inflammation diseases. 131336212141212121111122...
Invention Biomarkers, and uses in treatment of viral infections, inflammations, or cancer. The present disc...
Invention Quinoline derivatives for use in the treatment or prevention of cancer. 1313362121412121211111221...
Invention Process for preparing quinolin-2-yl-phenylamine derivatives and their salts. The present inventio...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (Ic) 4)alkoxy ...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound: 4)alkyl group, by a cycl...
Invention Aryl-n-aryl derivatives for treating a rna virus infection. A compound of formula (Ie): 2OH)—, a...
Invention Phenyl/pyridyl-n-phenyl/pyridyl derivatives for treating rna virus infection. The present inventi...
Invention Phenyl/pyridyl-n-phenyl/pyridyl derivatives for treating a rna virus infection. The present inven...
Invention Phenyl-n-quinoline derivatives for treating a rna virus infection. The present invention relates ...
Invention Compound, and production method thereof, and methods of treatment using the compound. The manufac...
2018 Invention Abx196 for use in the treatment of bladder cancer. The compound ABX196 and pharmaceutical composi...
Invention Abx196 for use in the treatment of bladder cancer. The present invention concerns the compound AB...
2017 Invention Antiviral polyclonal antibodies against ebola virus and the uses thereof. The present invention ...
2015 P/S Adjuvants à usage vaccinal, vaccins à usage humain, vaccins pour humains administrés par voie ora...
P/S Adjuvants for use as vaccines, preparations for vaccines for human use; preparations for vaccine...
P/S Adjuvants for use with vaccines; human vaccines preparations; oral vaccine preparations; pharmace...